Vagi-flora Rapid ve V-Flora kapsül Broşür Referans


vagi-flora-rapid-tablet
vflora-oral-kapsul
1- Bohbot JM, Cardot JM. Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women. Infect Dis Obstet Gynecol. 2012;2012:503648.
2- Forestier C et al. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol. 2001 Mar;152(2):167-73.
3- de Champs C et al. Persistence of colonization of intestinal mucosa by a probiotic strain, Lactobacillus casei subsp. rhamnosus Lcr35, after oral consumption. J Clin Microbiol. 2003 Mar;41(3):1270-3.
4- Vitali B et al. Management of disease and disorders by prebiotics and probiotic therapy: Probiotics in bacterial vaginosis. The Microbiota in Gastrointestinal Pathophysiology. 2017;:399–407.
5- Dausset C et al. Comparative phase I randomized open-label pilot clinical trial of Gynophilus® (Lcr regenerans®) immediate release capsules versus slow release muco-adhesive tablets. Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1869-1880.
6- Petricevic L, Witt A. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG. 2008 Oct;115(11):1369-74
7- Acartürk F. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul. 2009 Nov;3(3):193-205.
8- Dausset C et al. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35. Sci Rep 10, 17074 (2020).
Kullanma Talimatı
ASRAP